DIMENSIONAL FUND ADVISORS LP

Position in LQDA — Liquidia Corp

CIK 354204 AUSTIN, TX

Back to LQDA Full portfolio

Position in LQDA

as of Jun 30, 2026 · filed Aug 11, 2026 Compact

Position Value

$19,099,878

+$18,763,206 QoQ

Shares Held

239,557

+351.1% QoQ

Ownership

0.268%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#41

of 334 holders

Holding Since

Jun 2021

11 quarters on record

Voting authority Sole 79% Shared 2% None 19%

Common Shares in LQDA Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - Specialty & Generic

Healthcare · as of Jun 30, 2026

DIMENSIONAL FUND ADVISORS LP holds $3,170,376,127 across 48 Drug Manufacturers - Specialty & Generic names. LQDA ranks #23 (0.6% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	ELAN	Elanco Animal Health Inc	25,417,271	$625,519,037
2	VTRS	Viatris Inc	29,970,094	$475,925,092
3	UTHR	UNITED THERAPEUTICS Corp	527,904	$286,034,221
4	ALKS	Alkermes plc.	4,194,873	$219,811,343
5	LNTH	Lantheus Holdings, Inc.	1,466,260	$162,666,882
6	ZTS	Zoetis Inc.	2,173,278	$156,171,754
7	PBH	Prestige Consumer Healthcare Inc.	2,661,291	$125,799,224
8	NBIX	Neurocrine Biosciences Inc	732,877	$123,519,088

All Filings in LQDA

Export CSV

11 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$19,099,878	239,557	+351.1%	Shares	Sole	2026-08-11
2023-09-30	$336,672	53,103	-6.4%	Shares	Sole	2023-11-09
2023-06-30	$445,298	56,726	0.0%	Shares	Sole	2023-08-09
2023-03-31	$391,975	56,726	-11.0%	Shares	Sole	2023-05-12
2022-12-31	$406,189	63,766	+0.0%	Shares	Sole	2023-02-09
2022-09-30	$346,821	63,754	0.0%	Shares	Sole	2022-11-10
2022-06-30	$277,967	63,754	-14.2%	Shares	Sole	2022-08-12
2022-03-31	$533,524	74,307	+56.8%	Shares	Sole	2022-05-13
2021-12-31	$230,833	47,399	+299.6%	Shares	Defined	2022-02-09
2021-09-30	$32,739	11,862	-28.2%	Shares	Defined	2021-11-12
2021-06-30	$47,232	16,515	—	Shares	Defined	2021-08-12
No filing history on record for this holder in this stock.